Musa Khaitov

ORCID: 0000-0003-4961-9640
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Food Allergy and Anaphylaxis Research
  • Respiratory viral infections research
  • RNA Interference and Gene Delivery
  • IL-33, ST2, and ILC Pathways
  • Dermatology and Skin Diseases
  • Pediatric health and respiratory diseases
  • SARS-CoV-2 and COVID-19 Research
  • Advanced biosensing and bioanalysis techniques
  • Fullerene Chemistry and Applications
  • COVID-19 Clinical Research Studies
  • Respiratory and Cough-Related Research
  • Contact Dermatitis and Allergies
  • Antimicrobial Peptides and Activities
  • Immune Cell Function and Interaction
  • Sinusitis and nasal conditions
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • Neonatal Respiratory Health Research
  • Eosinophilic Esophagitis
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies
  • Immunotherapy and Immune Responses
  • Virus-based gene therapy research

Federal Medical-Biological Agency
2016-2025

Pirogov Russian National Research Medical University
2021-2025

Institute of Immunology and Physiology
2015-2024

Ministry of Health of the Russian Federation
2023-2024

Institute of Immunology
2007-2024

Peoples' Friendship University of Russia
2023-2024

State Research Institute of Highly Pure Biopreparations
2024

Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences
2023

Kharkiv Medical Academy of Postgraduate Education
2023

Charité - Universitätsmedizin Berlin
2021

Rhinoviruses are the major cause of asthma exacerbations; however, its underlying mechanisms poorly understood. We hypothesized that epithelial cell-derived cytokine IL-33 plays a central role in exacerbation pathogenesis through augmentation type 2 inflammation.To assess whether rhinovirus induces inflammatory response vivo and to define for this pathway.We used human experimental model infection novel airway sampling techniques measure IL-4, IL-5, IL-13, levels asthmatic healthy airways...

10.1164/rccm.201406-1039oc article EN American Journal of Respiratory and Critical Care Medicine 2014-10-28

Respiratory viruses, predominantly rhinoviruses are the major cause of asthma exacerbations. Impaired production interferon-beta in rhinovirus infected bronchial epithelial cells (BECs) and newly discovered interferon-lambdas both BECs bronchoalveolar lavage cells, is implicated exacerbation pathogenesis. Thus replacement deficient interferon a candidate new therapy for Rhinoviruses other respiratory viruses infect macrophages, but their relative capacities alpha-, beta- lambda-interferon...

10.1111/j.1398-9995.2008.01826.x article EN Allergy 2009-01-28

First vaccines for prevention of Coronavirus disease 2019 (COVID-19) are becoming available but there is a huge and unmet need specific forms treatment. In this study we aimed to evaluate the anti-SARS-CoV-2 effect siRNA both in vitro vivo.To identify most effective molecule out panel 15 silico designed siRNAs, an screening system based on vectors expressing SARS-CoV-2 genes fused with firefly luciferase reporter gene SARS-CoV-2-infected cells was used. The potent siRNA, siR-7, modified by...

10.1111/all.14850 article EN Allergy 2021-04-10
Jean Bousquet Marek Jutel Cezmi A. Akdiş Ludger Klimek Oliver Pfaar and 95 more Kari C. Nadeau Thomas Eiwegger Anna Bedbrook Ignacio J. Ansotegui Josep M Antó Claus Bachert Eric Bateman Kazi S. Bennoor Camelia Elena Berghea Karl‐Christian Bergmann Hubert Blain Mateo Bonini Sinthia Bosnic‐Anticevich Louis‐Philippe Boulet Luisa Brussino Roland Buhl Paulo Augusto Moreira Camargos Giorgio Walter Canonica Victòria Cardona Thomas B. Casale R. Sharon Chinthrajah Mübeccel Akdiş Tomás Chivato George Christoff Álvaro A. Cruz Heather J. Zar Stefano Del Giacco Hui Du Yehia El‐Gamal Wytske J. Fokkens João Fonseca Yadong Gao Mina Gaga Bilun Gemicioğlu Maia Gotua Tari Haahtela David Halpin Eckard Hamelmann Karin Hoffmann‐Sommergruber Marc Humbert N I Ilina Juan Carlos Ivancevich Guy Joos Musa Khaitov Bruce Kirenga Edward F. Knol Fanny W.S. Ko Seppo Koskinen Marek L. Kowalski Helga Kraxner D.А. Кudlay Piotr Kuna Maciej Kupczyk Violeta Kvedarienė Amir Hamzah Abdul Latiff Lan T. Le Michael Levin Désirée Larenas‐Linnemann Renaud Louis Mohammad Reza Masjedi Erik Melén Florin Mihaltan Branislava Milenković Yousser Mohammad Mário Morais‐Almeida Joaquim Mullol Leyla S. Namazova-Baranova Hugo Neffen Elisabete Nunes Paul M. O’Byrne Robyn E. O’Hehir Liam O’Mahony Ken Ohta Yoshitaka Okamoto Gabrielle L. Onorato Petr Panzner Nikolaos G. Papadopoulos Gianni Passalacqua Vincenzo Patella Ruby Pawankar N. Pham‐Thi Bernard Pigearias Todor A. Popov Francesca Puggioni Frederico S. Regateiro Giovanni Rolla Menachem Rottem Bolesław Samoliński J. Sastre Jürgen Schwarze Aziz Sheikh Nicola Scichilone Manuel Soto-Quirós Manuel E. Soto‐Martínez Milan Sova

To the Editor, A novel strain of human coronaviruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named by International Committee on Taxonomy Viruses (ICTV),1 has recently emerged and caused an infectious disease. This disease is referred to as "coronavirus 2019" (COVID-19) World Health Organization (WHO).2 The US Centers for Disease Control Prevention (CDC) have proposed that "People with moderate asthma may be at higher risk getting very sick from COVID-19. COVID-19 can...

10.1111/all.14471 article EN cc-by-nc Allergy 2020-06-27
Jan Hagemann Gabrielle L. Onorato Marek Jutel Cezmi A. Akdiş Ioana Agache and 95 more Torsten Zuberbier Heather J. Zar Joaquim Mullol Anna Bedbrook Claus Bachert Kazi Saifuddin Bennoor Karl‐Christian Bergmann Fulvio Braido Paulo Augusto Moreira Camargos Luis Caraballo Victòria Cardona Thomas B. Casale Lorenzo Cecchi Tomás Chivato Derek K. Chu Cemal Cingi Jaime Correia de Sousa Stefano Del Giacco D Dokic Mark S. Dykewicz Motohiro Ebisawa Yehia El‐Gamal R. Emuzyte Jean‐Luc Fauquert Alessandro Fiocchi Wytske J. Fokkens João Fonseca Bilun Gemicioğlu René‐Maximiliano Gomez Maia Gotua Tari Haahtela Eckard Hamelmann Tomohisa Iinuma Juan Carlos Ivancevich Ewa Jassem Ömer Kalaycı Przemysław Kardas Musa Khaitov Piotr Kuna Violeta Kvedarienė Désirée Larenas‐Linnemann Brian J. Lipworth Michaël Makris Jorge Máspero Neven Miculinić Florin Mihălţan Yousser Mohammad Stephen Montefort Mário Morais‐Almeida Ralph Mösges Robert M. Naclerio Hugo Neffen Marek Niedoszytko Robyn E. O’Hehir Ken Ohta Yoshitaka Okamoto Kimi Okubo Petr Panzner Nikolaos G. Papadopoulos Giovanni Passalacqua Vincenzo Patella Ana Margarida Pereira Oliver Pfaar Davor Plavec Todor A. Popov Emmanuel P. Prokopakis Francesca Puggioni Filip Raciborski Jere Reijula Frederico S. Regateiro Sietze Reitsma Antonino Romano Nelson Augusto Rosário Filho Menachem Rottem Dermot Ryan Bolesław Samoliński J. Sastre Dirceu Solé Milan Sova Cristiana Stellato Charlotte Suppli‐Ulrik Ioanna Tsiligianni Antonio Valero Arūnas Valiulis Erkka Valovirta Tuula Vasankari Maria Teresa Ventura Dana Wallace De Yun Wang Siân Williams Arzu Yorgancıoğlu Osman Yusuf Mario Zernotti Jean Bousquet Ludger Klimek

Although there are many asymptomatic patients, one of the problems COVID-19 is early recognition disease. symptoms polymorphic and may include upper respiratory symptoms. However, be mistaken with common cold or allergic rhinitis. An ARIA-EAACI study group attempted to differentiate between three diseases.A modified Delphi process was used. The ARIA members who were seeing patients asked fill in a questionnaire on airway COVID-19, rhinitis.Among 192 invited respond questionnaire, 89...

10.1111/all.14815 article EN Allergy 2021-03-17

Water-soluble form of fullerene C60 is a promising tool for the control ROS-dependent inflammation including allergic diseases. Anti-inflammatory effects (nC60) aqueous dispersion were evaluated in mouse models atopic dermatitis using subcutaneous (SC) and epicutaneous (EC) applications during 50 days period. A highly stable nC60 was prepared by exhaustive dialysis water-organic solution against water, where size ζ-potential nanoparticles are about 100 nm −30 mV, respectively. To induce skin...

10.1186/s12951-016-0159-z article EN cc-by Journal of Nanobiotechnology 2016-01-25
Jean Bousquet Oliver Pfaar Ioana Agache Anna Bedbrook Cezmi A. Akdiş and 95 more Giorgio Walter Canonica Tomás Chivato Mona Al‐Ahmad Amir Hamzah Abdul Latiff Ignacio J. Ansotegui Claus Bachert Baharuddin Abdullah Karl‐Christian Bergmann Carsten Bindslev‐Jensen Leif Bjermer Matteo Bonini Sinthia Bosnic‐Anticevich Isabelle Bossé Helen A. Brough Luisa Brussino Moisés A. Calderón Luis Caraballo Victòria Cardona Pedro Martins Thomas B. Casale Lorenzo Cecchi A. M. Cepeda Sarabia E. Chkhartishvili Derek K. Chu Ieva Cīrule Álvaro A. Cruz Heather J. Zar Stefano Del Giacco Pascal Demoly Philippe Devillier D Dokic Stephen L Durham Motohiro Ebisawa Yehia El‐Gamal R. Emuzyte Amiran Gamkrelidze J.-L. Fauquert Alessandro Fiocchi Wytske J. Fokkens João Fonseca J.F. Fontaine Radosław Gawlik Aslı Gelincik Bilun Gemicioğlu José E. Gereda Roy Gerth van Wijk René Maximiliano Gómez Maia Gotua Ineta Grisle Maria‐Antonieta Guzmán Tari Haahtela Susanne Halken Enrico Heffler Karin Hoffmann‐Sommergruber Elham Hossny M Hrubiško Carla Irani Juan Carlos Ivancevich Zhanat Ispayeva Kaja Julge Ігор Петрович Кайдашев Ömer Kalaycı Musa Khaitov Ludger Klimek Edward F. Knol Marek L. Kowalski Helga Kraxner Inger Kull Piotr Kuna Violeta Kvedarienė Vicky Kritikos Antti Lauerma Susanne Lau Daniel Laune Michael Levin D Larenas-Linnemann Karin C. Lødrup Carlsen Carlo Lombardi Olga Lourenço Bassam Mahboub Hans‐Jørgen Malling Patrick J. Manning Gailen D. Marshall Erik Melén Eli O. Meltzer Neven Miculinić Branislava Milenković Mostafa Moin Stephen Montefort Mário Morais‐Almeida Charlotte G. Mørtz Ralph Mösges Joaquim Mullol Leyla S. Namazova-Baranova Hugo Neffen

10.1002/clt2.12014 article EN Clinical and Translational Allergy 2021-06-01

During the ongoing coronavirus disease 2019 (COVID-19) pandemic, many individuals were infected with and have cleared virus, developing virus-specific antibodies effector/memory T cells. An important unanswered question is what levels of T-cell antibody responses are sufficient to protect from infection.

10.1093/cid/ciac278 article EN cc-by-nc-nd Clinical Infectious Diseases 2022-04-12

Severe acute respiratory syndrome corona virus (SARS-CoV-2) infection frequently causes severe and prolonged disease but only few specific treatments are available. We aimed to investigate safety efficacy of a SARS-CoV-2-specific siRNA-peptide dendrimer formulation MIR 19® (siR-7-EM/KK-46) targeting conserved sequence in known SARS-CoV-2 variants for treatment COVID-19.We conducted an open-label, randomized, controlled multicenter phase II trial (NCT05184127) evaluating inhaled...

10.1111/all.15663 article EN cc-by-nc Allergy 2023-02-01
Coming Soon ...